News Akero Therapeutics, Inc.

Equities

AKRO

US00973Y1082

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
19.74 ^USD	+4.28%		-4.91%	-15.46%

03-08	Akero Therapeutics Raises $367 Million From Share Offering	MT
03-07	Akero Therapeutics, Inc. Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

6 Stocks Positioned to Soar as Investors Focus on MASH	04-22	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO	04-20	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Akero Therapeutics, Inc. - AKRO	04-05	PR
Ademi LLP Investigates Claims of Securities Fraud against Akero Therapeutics, Inc.	04-02	PR
Akero Therapeutics Raises $367 Million From Share Offering	03-08	MT
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	03-08	GL
Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares	03-08	AQ
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	03-07	GL
Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	03-07	AQ
Akero Therapeutics, Inc. Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology	03-07	CI
Akero Therapeutics Insider Sold Shares Worth $732,727, According to a Recent SEC Filing	03-07	MT
Akero Therapeutics Insider Sold Shares Worth $2,465,063, According to a Recent SEC Filing	03-07	MT
Akero Therapeutics Announces Pricing of Public Offering of Common Stock	03-06	GL
UBS Adjusts Akero Therapeutics Price Target to $42 From $39, Maintains Buy Rating	03-05	MT
HC Wainwright Raises Price Target on Akero Therapeutics to $50 From $43, Maintains Buy Rating	03-05	MT
Health Care Down on Growth Doubts -- Health Care Roundup	03-04	DJ
Akero Therapeutics Proposes $300 Million Common Stock Offering -- Stock Down After Hours	03-04	MT
Akero Therapeutics Announces Proposed Public Offering of Common Stock	03-04	GL
Sector Update: Health Care Stocks Lean Lower Pre-Bell Monday	03-04	MT
Sector Update: Health Care	03-04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Akero Therapeutics, Inc.

Equities

AKRO

US00973Y1082

Summary

Filters